)
Edge12 Dec 2025
Running on Clouds: The Story of On
The story of how a Swiss runner's pursuit of a new running sensation became On, aiming to be the most premium global sportswear brand worldwide.
Anixa Biosciences
Anixa Biosciences (ANIX) investor relations material
Anixa Biosciences Q4 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q4 2025 earnings summary12 Jan, 2026
Executive summary
Focused on developing oncology therapies and vaccines, with lead programs in CAR-T for ovarian cancer and vaccines for breast and ovarian cancer.
No revenue generated from therapeutics or vaccine programs to date; legacy revenue from technology licensing.
Completed Phase 1 trial for breast cancer vaccine with positive safety and immune response data; preparing for Phase 2.
Ongoing Phase 1 trial for ovarian cancer CAR-T therapy, with multiple dose cohorts completed and well-tolerated.
Financial highlights
No revenue in fiscal years 2025 and 2024; operations funded by cash, investments, and equity offerings.
Research and development expenses decreased to $5.1M in 2025 from $6.4M in 2024.
General and administrative expenses decreased to $6.6M in 2025 from $7.4M in 2024.
Net loss for 2025 was $11.0M, compared to $12.7M in 2024.
Cash, cash equivalents, and short-term investments at year-end 2025 totaled $15.2M, down from $19.9M in 2024.
Outlook and guidance
Existing liquidity expected to fund activities for at least the next twelve months.
No expectation of near-term revenue from current therapeutics or vaccine programs; focus remains on advancing clinical trials and seeking licensing opportunities.
May seek additional funding through equity or debt if needed.
Rationale for lira-cel patient re-dosing?
Breast cancer vaccine: Phase 2 study design?
What is the financial impact of NCI PREVENT?
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Next Anixa Biosciences earnings date
Q1 202613 Mar, 2026
Anixa Biosciences
Next Anixa Biosciences earnings date
Q1 202613 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Anixa Biosciences Inc is a biotechnology company focused on developing therapies and vaccines for cancer and infectious diseases. The company pursues programs in immunotherapy, cancer vaccines, and antiviral therapies through research partnerships and internal development. Anixa Biosciences operates in the early-stage biotechnology sector. The company is headquartered in San Jose, California, and its shares are listed on the NASDAQ.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage